Arch Biopartners Inc. (ACHFF) Comparison with companies in other sectors?

Arch Biopartners Inc. has a share price of 66.11M. You can analyze Arch Biopartners Inc. (ACHFF) competitors across different market sectors through stock heatmaps.

What are ACHFF's NET and operating margins?

Arch Biopartners Inc. (ACHFF) operating margin is around 12.16, and net profit margin is approximately 12.46 as of the latest reports.

In what way does ACHFF's earnings per share (EPS) trend reflect its financial momentum?

Arch Biopartners Inc. (ACHFF) EPS is -0.03 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Arch Biopartners Inc. is -41.47, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Arch Biopartners Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Arch Biopartners Inc. like P/E which is -36.56, P/B which is -25.99, and PEG which is -1.74. Compare them with sector averages to evaluate if the stock is priced fairly.

Arch Biopartners Inc.

ACHFF•PNK

Healthcare

Biotechnology

$1.23

$-0.03(-2.38%)

Arch Biopartners Inc. (ACHFF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.03

P/E Ratio

-41.47

ROE

0.53%

Net Margin

12.46%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$82.24M

Shares OutstandingTotal number of shares issued

$66.11M

Book Value/ShareNet worth per share

$-0.07

Revenue/ShareAnnual revenue per share

$-0.00

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.03

Net MarginNet income as percentage of revenue

1245.81%

Operating MarginOperating income as percentage of revenue

1215.79%

ROEReturn on shareholders' equity

52.67%

ROAReturn on total assets

-567.73%

ROCEReturn on capital employed

69.39%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.03

Cash/ShareCash and equivalents per share

$0.001

FCF YieldFree cash flow as percentage of market cap

-1.96%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ACHFFFinancial Ratios Analysis details for ACHFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ACHFFSector Benchmarking details for ACHFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Arch Biopartners Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Arch Biopartners Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Arch Biopartners Inc.'s unique business strengths and challenges.

Key Financial Metrics for Arch Biopartners Inc.

For Arch Biopartners Inc., essential financial indicators include EPS -0.03, PE -41.47, and ROE 0.53. These key ratios reveal insights into Arch Biopartners Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Arch Biopartners Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Arch Biopartners Inc.

Metrics like Net Margin 1245.81% and ROA -567.73% shed light on how well Arch Biopartners Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Arch Biopartners Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Arch Biopartners Inc.

Using ratios such as P/B Ratio -25.99 and PEG Ratio -1.74, investors can assess whether Arch Biopartners Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Arch Biopartners Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Arch Biopartners Inc.

Financial health indicators, such as Debt/Equity Ratio -0.66 and Cash Flow $-0.03, provide a snapshot of Arch Biopartners Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Arch Biopartners Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Arch Biopartners Inc.

Investing in Arch Biopartners Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Arch Biopartners Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;